comprehensive -WSS

comprehensive

author：explore 2025-10-04 07:30:14 - browse：74

Patient treated with Impella in the heart. -- health tech coverage from STAT — Abiomed, which was bought by Johnson & Johnson late last year for $16.6 billion, sells devices for heart failure patients as well as patient monitoring software. Business Wire

The Food and Drug Administration is following through on its promise to regulate more health software tools, starting with a public reprimand of Johnson & Johnson’s heart pump company, Abiomed.

Abiomed, which was bought by Johnson & Johnson late last year for $16.6 billion, sells devices for heart failure patients as well as patient monitoring software. The FDA published a warning letter on Wednesday telling the company it should have submitted its software for approval before putting it on the market. The agency also took issue with Abiomed’s failure to report various problems with its heart pumps.

The letter comes a year after the Food and Drug Administration announced its intention to regulate more health software tools, sending the industry into an uproar.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Alkermes shareholders re
Next article： The inclusion problem at the heart of rehabilitation research

WSS

TikTok, Instagram influencers need more rules for drug ads

What nurses really want: sufficient staffing for patient care

How to improve immunocompromised access to mAb treatments

Medicare drug price lawsuits could be good politics for Biden

HPV vaccine, cervical cancer study delivers historic results

A pediatrician calls for Congress to pass the child tax credit deal

explore

comprehensive

hotspot

Indiana Supreme Court upholds abortion ban, says state constitution gives only limited protections

Pumping milk in bathrooms at health conferences is common

As demand for Covid shots wanes, Moderna seeks its next success

Software glitch causes Tandem insulin pump to shutdown, FDA warns

Alkermes shareholders re

What causes osteoarthritis? Researchers study link to brain protein

Drug repurposing or repositioning? The language matters

Immunocompromised patients offer clues on chronic Covid

Food as medicine: CMS rules hamper 'prescribing' of fruits, veggies

There's an unseen cost to disruptive road

explore

Dog Aging Project founders on what lies ahead after losing funding

Cardiologists urge adding sexual orientation, gender identity to health records

Researchers on aging grapple with how to calculate biological age

High breast density mammograms need follow

Medicare says breakthrough device reimbursement rule to come by summer

FDA sets aggressive timeline for overhauling inspection procedures

explore

focus

leisure time

leisure time